Cell Sheet Migration Inhibitor, Locostatin (CAS 133812-16-5)

Cell Sheet Migration Inhibitor, Locostatin, has emerged as a valuable tool in cell biology research, particularly in elucidating the molecular mechanisms underlying cell migration and invasion. Mechanistically, Locostatin exerts its effects by inhibiting the activity of lysyl oxidase-like 2 (LOXL2), a member of the lysyl oxidase family of enzymes implicated in extracellular matrix remodeling and cell motility. Through its interaction with LOXL2, Locostatin disrupts the cross-linking of collagen fibers, leading to alterations in the mechanical properties of the extracellular matrix and impairing cell migration. In research, Locostatin has been extensively utilized to investigate the role of LOXL2 in cancer metastasis, fibrosis, and tissue regeneration, providing insights into the molecular pathways regulating these processes. Furthermore, its use in in vitro models, such as cell migration assays and three-dimensional culture systems, has facilitated the study of cell-ECM interactions and the identification of novel targets for intervention. Additionally, Locostatin′s specificity for LOXL2 has enabled researchers to dissect the individual contributions of lysyl oxidase family members to cellular processes, informing the development of targeted therapies aimed at modulating ECM remodeling and cell migration in various pathological conditions. Overall, Locostatin serves as a valuable research tool in cell biology, offering insights into the molecular mechanisms of cell migration and invasion, and guiding the development of novel strategies for cancer and fibrotic diseases.